Business Context and Reporting Period
This Form 8-K was filed by Pono Capital Two, Inc. on March 1, 2024, reporting events occurring on February 27, 2024. Pono is pursuing a proposed business combination with SBC Medical Group Holdings Incorporated, with SBC expected to survive the merger. The filing is not an operating or quarterly financial-results report.
Key Financial and Capital Structure Metrics
- Pono amended its Note Purchase Agreement with SBC and increased the purchase price and principal amount of a convertible promissory note from $1.0 million to $2.7 million.
- The original note was issued and funded on May 26, 2023.
- The amended note provides for conversion into 270,000 shares of common stock, subject to its terms and conditions.
- The shares are being issued in an unregistered transaction under the Securities Act Section 4(a)(2) exemption.
- The filing provides no revenue, profit, cash-flow, margin, operating expense, or liquidity metrics for SBC or Pono.
Material Changes Versus the Prior Comparable Period
The material change is the increase in the convertible note’s purchase price and principal amount from $1.0 million to $2.7 million, together with the associated potential issuance of 270,000 common shares. In consideration for the amendment, the parties to the Merger Agreement agreed to release one another from claims arising from termination of the agreement or failure to consummate the proposed transactions.
Outlook, Risks, Contingencies, and Unusual Items
- The business combination remains subject to customary conditions, including Pono stockholder approval, and may not be completed or may be terminated.
- Identified risks include excessive shareholder redemptions, failure to satisfy Nasdaq initial listing standards, legal proceedings, disruption to SBC’s business, inability to realize anticipated transaction benefits, and the need to raise additional capital on acceptable terms.
- The filing cautions that financial projections, market-size statements, expected transaction benefits, liquidity, future performance, and other forward-looking information are subject to substantial uncertainty.
- The amendment and release of potential claims are unusual transaction-related items that may affect the parties’ rights if the merger is not completed.
- The filing states that the definitive proxy statement and related transaction materials will contain additional information and risk factors.
Investor Verification Checklist
- Verify the full terms of the amended convertible note, including conversion mechanics, maturity, interest, and any other rights or restrictions.
- Confirm whether and when the 270,000 shares may be issued and the resulting ownership and dilution implications.
- Review the amended Merger Agreement, the definitive proxy statement, and conditions required to close the business combination.
- Assess potential shareholder redemptions, Nasdaq listing compliance, and Pono’s available cash and financing needs.
- Review the parties’ latest SEC filings for financial statements, liquidity information, litigation, and additional transaction risks.